Related Experiment Video
Updated: Jun 12, 2025

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts
Published on: October 9, 2016
A shorter splicing isoform antagonizes ZBP1 to modulate cell death and inflammatory responses
Masahiro Nagata1,2, Yasmin Carvalho Schäfer1,2, Laurens Wachsmuth1,2
1Institute for Genetics, University of Cologne, D-50674, Cologne, Germany.
Abstract:
Z-DNA-binding protein 1 (ZBP1) is an interferon-inducible sensor of Z-DNA and Z-RNA, which has emerged as a critical regulator of cell death and inflammation. ZBP1 binds Z-DNA and Z-RNA via its Zα domains, and signals by engaging RIPK3 and RIPK1 via its RIP homotypic interaction motifs (RHIMs). Here, we show that mice express an alternatively-spliced shorter ZBP1 isoform (ZBP1-S), which harbours the Zα domains but lacks the RHIMs, and acts as an endogenous inhibitor of the full-length protein (ZBP1-L). Mice and cells expressing only ZBP1-S are resistant to ZBP1-mediated cell death and inflammation. In contrast, cells lacking ZBP1-S show increased ZBP1-L-induced death compared to cells expressing both isoforms. Moreover, loss of the short isoform accelerates and exacerbates skin inflammation induced by ZBP1-mediated necroptosis of RIPK1-deficient keratinocytes, revealing an important physiological role of ZBP1-S. Mechanistically, ZBP1-S suppresses ZBP1-L-mediated cell death by binding to Z-nucleic acids via its Zα domains. Therefore, ZBP1-S acts as an endogenous inhibitor that competes with full-length ZBP1-L for binding Z-nucleic acid ligands to fine-tune ZBP1-mediated cell death and inflammation.
Insights
A newly discovered short ZBP1 isoform (ZBP1-S) inhibits full-length ZBP1-L, acting as a crucial regulator of Z-DNA-mediated cell death and inflammation.
Area of Science:
- Immunology
- Molecular Biology
- Cell Death Research
Background:
- Z-DNA-binding protein 1 (ZBP1) is an interferon-inducible sensor protein.
- ZBP1 regulates cell death and inflammation by binding Z-DNA/Z-RNA and interacting with RIPK1/RIPK3.
- The precise regulation of ZBP1 activity in vivo is not fully understood.
Purpose of the Study:
- To investigate the existence and function of alternatively spliced ZBP1 isoforms.
- To determine the role of a newly identified ZBP1 isoform in regulating ZBP1-mediated cell death and inflammation.
Main Methods:
- Analysis of ZBP1 splicing variants in mice.
- Cellular and in vivo studies using knockout and knockdown models.
- Assessment of cell death, necroptosis, and inflammatory responses.
Main Results:
- Identification of an alternatively spliced ZBP1 isoform, ZBP1-S, lacking RIP homotypic interaction motifs (RHIMs).
- ZBP1-S acts as an endogenous inhibitor of full-length ZBP1-L by competing for Z-nucleic acid binding.
- Mice and cells lacking ZBP1-S exhibit heightened ZBP1-L-induced cell death and inflammation, particularly skin inflammation.
Conclusions:
- ZBP1-S is a critical endogenous inhibitor that fine-tunes ZBP1-L activity.
- This regulatory mechanism is essential for preventing excessive ZBP1-mediated cell death and inflammation.
- ZBP1-S plays a significant physiological role in immune homeostasis and inflammatory control.
Related Concept Videos
RNA Splicing
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
The JAK-STAT Signaling Pathway

